Generic Valtrex Launch Likely Delayed Pending Resolution Of GSK/Ranbaxy Suit
This article was originally published in The Pink Sheet Daily
Executive Summary
GlaxoSmithKline says it will file a motion for preliminary injunction to block Ranbaxy from launching generic valacyclovir.
You may also be interested in...
Ranbaxy Will Launch Generic Valtrex After GlaxoSmithKline Patent Expires In 2009
Indian firm also licensed two process patents related to the herpes virus treatment after the firms resolved a patent infringement dispute.
Hologic's Adiana Permanent Birth Control Device Takes On Conceptus' Essure
Adiana uses a polymer matrix insert to block the fallopian tubes instead of a metal coil, offering a benefit over Essure, which carries a perforation risk on implantation, Hologic exec says.